Fundraising FoxHI-Bio
acquired by Biogen7 known investors
Find your way into HI-Bio
Biotech company developing antibodies to treat autoimmune and inflammatory diseases.
Investors · 7
Alpha Wave Globallisted by Alpha Wave GlobalMiami
How we know: Alpha Wave Global's portfolio page · prnewswire.com · Not right? Tell us
Arkin Capitallisted by Arkin CapitalHerzliya
How we know: Arkin Capital's portfolio page · Not right? Tell us
Jeito Capitallisted by Jeito CapitalParis
How we know: Jeito Capital's portfolio page · prnewswire.com · Not right? Tell us
Monograph Capital Partnerslisted by Monograph Capital PartnersLondon
How we know: press coverage · funding news · Not right? Tell us
ARCH Venture PartnersreportedChicago · $50K – $250M
How we know: a partner's Signal profile · prnewswire.com · funding news · Not right? Tell us
Also in the syndicate · 1
Arkin Bio Capital
Funding
SEC filings, press & company announcements$95M disclosed across 1 round · 2024
- $95MSeries BJan 2024 · 2 sources
Alpha Wave Global (lead), ARCH Venture Partners, Arkin Bio Capital, Jeito Capital, Viking Global Investors
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does HI-Bio do?
- Biotech company developing antibodies to treat autoimmune and inflammatory diseases.
- Who are HI-Bio's investors?
- HI-Bio's investors include Alpha Wave Global, Arkin Capital, Jeito Capital, Monograph Capital Partners, ARCH Venture Partners, Viking Global Investors.
- How much funding has HI-Bio raised?
- HI-Bio has disclosed $95M raised across 1 round.
- Who acquired HI-Bio?
- HI-Bio was acquired by Biogen.